BlackRock Global Funds - Global Equity Income Fund A8 CNH HedgedRegister to Unlock Ratings |
Performance History | 30/04/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 11.0 | 23.2 | -12.2 | 2.6 | 1.0 | |
+/-Cat | - | - | - | - | - | |
+/-B’mrk | - | - | - | - | - | |
Category: Other Equity | ||||||
Category Benchmark: - |
Key Stats | ||
NAV 17/05/2024 | CNH 125.40 | |
Day Change | -0.37% | |
Morningstar Category™ | Other Equity | |
ISIN | LU1220226846 | |
Fund Size (Mil) 30/04/2024 | USD 905.80 | |
Share Class Size (Mil) 17/05/2024 | CNY 6.04 | |
Max Initial Charge | 5.00% | |
Ongoing Charge 09/02/2023 | 1.82% |
Investment Objective: BlackRock Global Funds - Global Equity Income Fund A8 CNH Hedged |
The Fund seeks an above average income from its equity investments without sacrificing long term capital growth. The Fund invests globally at least 70% of its total assets in the equity securities of companies domiciled in, or exercising the predominant part of their economic activity in, developed markets. Currency exposure is flexibly managed. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Olivia Treharne 01/02/2020 | ||
Molly Greenen 12/01/2022 | ||
Inception Date 22/04/2015 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI ACWI NR USD | - |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for BlackRock Global Funds - Global Equity Income Fund A8 CNH Hedged | 30/04/2024 |
|
|
Top 5 Holdings | Sector | % |
Microsoft Corp | Technology | 4.70 |
AstraZeneca PLC | Healthcare | 3.39 |
Novo Nordisk A/S Class B | Healthcare | 3.27 |
Taiwan Semiconductor Manufacturi... | Technology | 3.14 |
Texas Instruments Inc | Technology | 3.06 |
Increase Decrease New since last portfolio | ||
BlackRock Global Funds - Global Equity Income Fund A8 CNH Hedged |